BRPI0507634A - processo para preparação de compostos triazóis substituìdos - Google Patents

processo para preparação de compostos triazóis substituìdos

Info

Publication number
BRPI0507634A
BRPI0507634A BRPI0507634-0A BRPI0507634A BRPI0507634A BR PI0507634 A BRPI0507634 A BR PI0507634A BR PI0507634 A BRPI0507634 A BR PI0507634A BR PI0507634 A BRPI0507634 A BR PI0507634A
Authority
BR
Brazil
Prior art keywords
substituted triazole
triazole compounds
preparing substituted
present
compounds
Prior art date
Application number
BRPI0507634-0A
Other languages
English (en)
Inventor
David C Palmer
Kirk L Sorgi
Sergio Cesco-Cancian
Tong Xiao
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34864531&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0507634(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BRPI0507634A publication Critical patent/BRPI0507634A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCESSO PARA PREPARAçãO DE COMPOSTOS TRIAZóIS SUBSTITUìDOS. A presente invenção é um novo processo para a preparação de compostos triazóis substituídos, úteis no tratamento ou melhora de um distúrbio mediado por cinase-dual ou cinase seletiva. O processo da presente invenção preferencialmente produz o desejado regiosómero dos compostos triazóis substituídos.
BRPI0507634-0A 2004-02-11 2005-01-21 processo para preparação de compostos triazóis substituìdos BRPI0507634A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54372104P 2004-02-11 2004-02-11
US62368104P 2004-10-29 2004-10-29
PCT/US2005/001917 WO2005077922A2 (en) 2004-02-11 2005-01-21 Process for the preparation of substituted triazole compounds

Publications (1)

Publication Number Publication Date
BRPI0507634A true BRPI0507634A (pt) 2007-07-03

Family

ID=34864531

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507634-0A BRPI0507634A (pt) 2004-02-11 2005-01-21 processo para preparação de compostos triazóis substituìdos

Country Status (16)

Country Link
US (1) US20060100259A1 (pt)
EP (1) EP1720843A2 (pt)
JP (1) JP2007522213A (pt)
KR (1) KR20070036025A (pt)
AR (1) AR047544A1 (pt)
AU (1) AU2005212218A1 (pt)
BR (1) BRPI0507634A (pt)
CA (1) CA2555825A1 (pt)
CR (1) CR8562A (pt)
EA (1) EA200601441A1 (pt)
EC (1) ECSP066768A (pt)
IL (1) IL177315A0 (pt)
MX (1) MXPA06009193A (pt)
NO (1) NO20063991L (pt)
TW (1) TW200538116A (pt)
WO (1) WO2005077922A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008515925A (ja) * 2004-10-08 2008-05-15 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ １，２，４−トリアゾリルアミノアリール（ヘテロアリール）スルホンアミド誘導体
US7884119B2 (en) 2005-09-07 2011-02-08 Rigel Pharmaceuticals, Inc. Triazole derivatives useful as Axl inhibitors
JP2010514810A (ja) 2006-12-29 2010-05-06 ライジェル ファーマシューティカルズ， インコーポレイテッド Ａｘｌインヒビターとして有用な置換トリアゾール
AU2007342005A1 (en) 2006-12-29 2008-07-10 Rigel Pharmaceuticals, Inc. N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as Axl inhibitors
EP2114954B1 (en) 2006-12-29 2013-02-13 Rigel Pharmaceuticals, Inc. Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors
ES2404668T3 (es) 2006-12-29 2013-05-28 Rigel Pharmaceuticals, Inc. Triazoles sustituidos con arilo bicíclico puenteado y heteroarilo bicíclico puenteado, útiles como agentes inhibidores del axl
PT2078010E (pt) 2006-12-29 2014-05-07 Rigel Pharmaceuticals Inc Triazoles substituídos com heteroarilos policíclicos úteis como inibidores de axl
CA2704052C (en) 2007-10-26 2015-04-21 Rigel Pharmaceuticals, Inc. Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
JP5592884B2 (ja) 2008-07-09 2014-09-17 ライジェル ファーマシューティカルズ， インコーポレイテッド Ａｘｌ阻害剤として有用な多環式ヘテロアリール置換トリアゾール
US8431594B2 (en) 2008-07-09 2013-04-30 Rigel Pharmaceuticals, Inc. Bridged bicyclic heteroaryl substituted triazoles useful as AXL inhibitors
RU2555326C2 (ru) 2009-01-16 2015-07-10 Риджел Фармасьютикалз, Инк. ИНГИБИТОРЫ Axl ДЛЯ ПРИМЕНЕНИЯ В КОМБИНИРОВАННОЙ ТЕРАПИИ ДЛЯ ПРЕДОТВРАЩЕНИЯ, УСТРАНЕНИЯ ИЛИ ЛЕЧЕНИЯ МЕТАСТAЗИРУЮЩЕГО РАКА
US20140010783A1 (en) * 2012-07-06 2014-01-09 Hoffmann-La Roche Inc. Antiviral compounds
CN116003336B (zh) * 2023-01-09 2024-11-05 赣南师范大学 一种1,2,4-三氮唑-3-胺类化合物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2432870A1 (en) * 2000-12-22 2002-07-25 Ronghui Lin Substituted triazole diamine derivatives as kinase inhibitors
AR042052A1 (es) * 2002-11-15 2005-06-08 Vertex Pharma Diaminotriazoles utiles como inhibidores de proteinquinasas

Also Published As

Publication number Publication date
IL177315A0 (en) 2006-12-10
TW200538116A (en) 2005-12-01
WO2005077922A2 (en) 2005-08-25
JP2007522213A (ja) 2007-08-09
NO20063991L (no) 2006-11-08
KR20070036025A (ko) 2007-04-02
WO2005077922A3 (en) 2006-01-26
EA200601441A1 (ru) 2007-02-27
MXPA06009193A (es) 2007-01-26
AU2005212218A1 (en) 2005-08-25
US20060100259A1 (en) 2006-05-11
EP1720843A2 (en) 2006-11-15
AR047544A1 (es) 2006-01-25
CA2555825A1 (en) 2005-08-25
ECSP066768A (es) 2006-11-16
CR8562A (es) 2008-09-09

Similar Documents

Publication Publication Date Title
LTC1971601I2 (pt)
WO2007092879A3 (en) Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors
WO2007127505A3 (en) Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system
WO2007084815A3 (en) Substituted thienopyrimidine kinase inhibitors
CO6150162A2 (es) Pirrolopirimidinas para composiciones farmaceuticas
BR0208373A (pt) Inibidores da tirosina cinase
MX2009004791A (es) Derivados de anilinopiperazina t metodos de uso de los mismos.
MY145070A (en) Imidazolothiazole compounds for the treatment of disease
WO2007109783A3 (en) Substituted pyrimidine kinase inhibitors
MX2010002732A (es) Inhibidores de f1f0-atpasa y metodos relacionados.
MX2009004785A (es) Amidas 2-aminotiazol-4-carboxilicas como inhibidores de proteina quinasa.
WO2006009836A3 (en) Tdf-related compounds and analogs thereof
TW200732296A (en) Novel compounds
BRPI0809996B8 (pt) compostos, seus usos para tratar um distúrbio proliferativo, viral, neurodegenerativo, do snc, diabetes, alopecia e um acidente vascular cerebral, e composições farmacêuticas
WO2008045371A3 (en) N-substituted-azacyclylamines as histamine-3 antagonists
WO2007079214A3 (en) Prokineticin 2 receptor antagonists
TW200736229A (en) Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
MX2007002470A (es) Fenilaminotiazoles sustituidos y su uso.
WO2007081630A3 (en) Substituted pyrimidinyl kinase inhibitors
MX2007011847A (es) Derivados de pirimidindiona como antagonistas del receptor de procineticina 2.
BRPI0607792A2 (pt) processo para a preparação de moduladores de opióides
BRPI0407913A (pt) antagonistas receptores de ccr-3
EP3912980A4 (en) CYCLIC MOLECULES AS INHIBITORS OF BRUTON'S TYROSINE KINASE
WO2007035872A3 (en) Tdf-related compounds and analogs thereof
BRPI0615272A2 (pt) inibidores de p38 map kinase e métodos para uso dos mesmos

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]